These findings suggest that the baseline IFNγ level found in cluster 1 is independent of the caspase-1/IL18 axis and that the activation of the caspase-1/IL18 axis in tumor cells could facilitate the anti-tumor IFNγ response. The gene discussed is IFNG; the disease is neoplasm.